Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway

Figure 4

NCL regulates YB1 expression. (a) Schematic representation of human MDR1 gene promoter that contains a binding site for YB1. (b) Western blot analysis and (c) quantification of YB1 expression in NCL overexpression Hela cells with or without DDP treatment. (d, e) The same as that in (b) and (c), but in the NCL knockdown cells.

(a)

(b)

(c)

(d)

(e)